Literature DB >> 19166663

The impact of MELD allocation on simultaneous liver-kidney transplantation.

Julie A Thompson1, John R Lake.   

Abstract

Model for End-Stage Liver Disease (MELD) allocation has improved the process for ranking patients on the liver transplant list. One unintended consequence has been an increase in the number of simultaneous liver-kidney (SLK) transplants. Some have argued that the system unfairly advantages patients with kidney disease and that some kidneys are being prematurely placed in SLK transplantation. This review summarizes the MELD score, assessment of kidney function in cirrhosis, the impact of kidney function in liver disease, and changes in kidney function status in liver transplant recipients in the MELD era. Finally, recommendations regarding who should receive SLK transplants are reviewed.

Entities:  

Mesh：

Year:  2009        PMID： 19166663     DOI： 10.1007/s11894-009-0012-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  35 in total

Review 1.  Identification of patients best suited for combined liver-kidney transplantation: part II.

Authors:  Connie L Davis; Thomas A Gonwa; Alan H Wilkinson
Journal:  Liver Transpl       Date:  2002-03       Impact factor: 5.799

Review 2.  Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.

Authors:  E Cholongitas; V Shusang; L Marelli; D Nair; M Thomas; D Patch; A Burns; P Sweny; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2007-10-01       Impact factor: 8.171

3.  Dialysis in non-renal organ (liver) transplantation.

Authors:  D Richardson
Journal:  Nephron       Date:  2001-08       Impact factor: 2.847

4.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Impact of dialysis and older age on survival after liver transplantation.

Authors:  E S Dellon; J A Galanko; R K Medapalli; M W Russo
Journal:  Am J Transplant       Date:  2006-07-06       Impact factor: 8.086

6.  Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

7.  Preemptive kidney transplantation: the advantage and the advantaged.

Authors:  Bertram L Kasiske; Jon J Snyder; Arthur J Matas; Mary D Ellison; John S Gill; Annamaria T Kausz
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

9.  Impact of pretransplant renal function on survival after liver transplantation.

Authors:  T A Gonwa; G B Klintmalm; M Levy; L S Jennings; R M Goldstein; B S Husberg
Journal:  Transplantation       Date:  1995-02-15       Impact factor: 4.939

10.  Liver and intestine transplantation in the United States, 1996-2005.

Authors:  E A Pomfret; J P Fryer; C S Sima; J R Lake; R M Merion
Journal:  Am J Transplant       Date:  2007       Impact factor: 8.086
View more
  3 in total

1.  Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.

Authors:  A L Mindikoglu; J P Raufman; S L Seliger; C D Howell; L S Magder
Journal:  Transplant Proc       Date:  2011-09       Impact factor: 1.066

2.  Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy.

Authors:  Yaojen Chang; Lorenzo Gallon; Colleen Jay; Kirti Shetty; Bing Ho; Josh Levitsky; Talia Baker; Daniela Ladner; John Friedewald; Michael Abecassis; Gordon Hazen; Anton I Skaro
Journal:  Liver Transpl       Date:  2014-09       Impact factor: 5.799

3.  Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Authors:  Christopher M Moore; David H Van Thiel
Journal:  World J Hepatol       Date:  2013-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.